Ettore Luzi

Phosphodiester oligonucleotides inhibit mitosis and trigger apoptosis by a non-antisense, p53-mediated mechanism.

Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme.

Multiple endocrine neoplasia type 1.

Multiple endocrine neoplasia type 2.

Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor.

Multiple endocrine neoplasms.

Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis.

Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report.

Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors.

Mammalian Pumilio 2 regulates dendrite morphogenesis and synaptic function.

Are microRNAs involved in the endocrine-specific pattern of tumorigenesis in multiple endocrine neoplasia type 1?

MicroRNA Role in Thyroid Cancer Development.

The regulatory network menin-microRNA 26a as a possible target for RNA-based therapy of bone diseases.

The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the "Knudson's second hit".

COL1A1 Sp1 variation and bone phenotypes in an Italian population.

PTH-C1: a rat continuous cell line expressing the parathyroid phenotype.

Osteogenic differentiation of adipose tissue-derived mesenchymal stem cells on nanostructured Ti6Al4V and Ti13Nb13Zr.

An autoregulatory network between menin and pri-miR-24-1 is required for the processing of its specific modulator miR-24-1 in BON1 cells.

RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cells.